首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Chinese medicine

缩写:CHIN MED-UK

ISSN:1749-8546

e-ISSN:1749-8546

IF/分区:7.4/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1655条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xin Yu,Siyang Wu,Huinan Wang et al. Xin Yu et al.
Background: Golden bile powder (GBP), an artificial bear bile powder, is used for liver protection and contains taurine-conjugated bile acids (BAs) with broad pharmacological activities. However, its pharmacokinetics and ...
Hyeonjeong Park,In Jin Ha,Young-Hee Jin et al. Hyeonjeong Park et al.
Background: The dried pericarp of Zanthoxylum bungeanum Maxim. (Rutaceae), widely recognized as Sichuan pepper (Hua Jiao), is a prominent herb within the Traditional Chinese Medicine (TCM), boasting a long and well-docume...
Shuoyan Tan,Xin Shao,Xuting Zhang et al. Shuoyan Tan et al.
Background: Artificial intelligence (AI), particularly large language models (LLMs), have provided powerful tools for systematically modeling the complexity of traditional Chinese medicine (TCM). To overcome the limitatio...
Li Li,Liying Xue,Chu Xue et al. Li Li et al.
Background: Tadehagi triquetrum, a well-known medicinal plant widely consumed in Asia, possesses hypoglycemic properties. However, its precise impact in managing diabetic complications remains insufficiently understood. T...
Zhi-Xian Jiang,Xue-Liang Chen,Qi Sun et al. Zhi-Xian Jiang et al.
Background: Dysbiosis during colitis alters the conversion of primary to secondary bile acids by gut microbiota, which affects bile acid receptor signaling and may exacerbate mucosal inflammation in experimental colitis m...
Jinli Hou,Sen Li,Fengrong Zhang et al. Jinli Hou et al.
Background: Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disorder with limited treatment options. Yindan Pinggan capsule (YDPG), a traditional Chinese medicine, has demonstrated potential in managing...
Xuemei Zhang,Liming Zheng,Jia Shi et al. Xuemei Zhang et al.
Hepatocellular carcinoma (HCC) is a highly aggressive malignancy characterized by complex metabolic dysregulation and immune evasion mechanisms, leading to poor prognosis and limited treatment efficacy. Growing evidence underscores the crit...
Yongfu Wang,Wei Liu,Pengzhuo Tao et al. Yongfu Wang et al.
Background: Lung adenocarcinoma (LUAD) is a leading cause of cancer death. Neurotensin receptor 1 (NTSR1), a G protein-coupled receptor, is overexpressed in LUAD and linked to poor prognosis, but its therapeutic potential...
Yinli Shi,Jun Liu,Guoduan Zeng et al. Yinli Shi et al.
Background: Bioinformatics and large-scale computational modelling have emerged as essential research fields in modern biomedical science, enabling drug discovery and therapeutic optimisation. A unique and potent technica...
Yi Zhang,Zihe Ding,Xiaoyue Wang et al. Yi Zhang et al.
Tripterygium glycosides tablets (TGT) are effective against autoimmune diseases but cause significant drug-induced liver injury (DILI) that limits clinical use. While TGT disrupts hepatic iron-lipid homeostasis and co-administration with To...